EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Exploring the dichotomy of the mesenchymal stem cell secretome: Implications for tumor modulation via cell-signaling pathways

Mohammad Rasouli, Mana Alavi, Alberto D'Angelo, Navid Sobhani, Raheleh Roudi, Fatemeh Safari

International Immunopharmacology · 2024-12 · 143 · 113265

DOI: 10.1016/j.intimp.2024.113265 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Immunopharmacology, 2024-12. Verfasst von Mohammad Rasouli und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Faculty of Science, University of Guilan, Rasht, Iran. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Signal Transduction, Neoplasms, Secretome. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 79 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Current cancer therapeutic strategies for the treatment of cancer are often unsuccessful due to unwanted side effects and drug resistance. Therefore, the design and development of potent, new anticancer platforms, such as stem-cell treatments, have attracted much attention. Distinctive biological properties of stem cells include their capacity to secrete bioactive factors, their limited immunogenicity, and their capacity for renewing themselves. Mesenchymal stem cells (MSCs) are one of several kinds of stem cells that are conveniently extracted and are able to be cultivated in vitro utilizing various sources. The secretome of stem cells contains many trophic factors, including cytokines, chemokines, growth factors, and microRNA molecules that can either promote or inhibit the formation of tumors, based on the cell environment. In the current review, we focused on the secretome of mesenchymal stem cells. These stem cells act as a double-edged sword in the regulation of cell signal transduction pathways in that they can either suppress or promote tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mesenchymal Stem CellsSignal TransductionNeoplasmsSecretomeHumansAnimals

Stichwörter der Autor:innen

Cell signal transduction pathwaysSecretome of MSCsTumor promotionTumor suppression

Autor:innen und Institutionen

  • Department of Biology, Faculty of Science, University of Guilan, Rasht, Iran.
  • Oncology Department, Royal United Hospital, Bath BA1 3NG, United Kingdom.
  • Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA.
  • Molecular Imaging Program at Stanford (MIPS), Department of Radiology, Stanford University, Stanford, CA 94305, USA. Electronic address: roudi@Stanford.edu.
  • Department of Biology, Faculty of Science, University of Guilan, Rasht, Iran. Electronic address: fsafari@guilan.ac.ir.

Zitieren

APA

Rasouli, M., Alavi, M., D'Angelo, A., Sobhani, N., Roudi, R., & Safari, F. (2024). Exploring the dichotomy of the mesenchymal stem cell secretome: Implications for tumor modulation via cell-signaling pathways. International Immunopharmacology, 143, 113265. https://doi.org/10.1016/j.intimp.2024.113265

Vancouver

Rasouli M, Alavi M, D'Angelo A, Sobhani N, Roudi R, Safari F. Exploring the dichotomy of the mesenchymal stem cell secretome: Implications for tumor modulation via cell-signaling pathways. International Immunopharmacology. 2024;143:113265. doi:10.1016/j.intimp.2024.113265

BibTeX
@article{Rasouli2024,
  author = {Rasouli, Mohammad and Alavi, Mana and D'Angelo, Alberto and Sobhani, Navid and Roudi, Raheleh and Safari, Fatemeh},
  title = {Exploring the dichotomy of the mesenchymal stem cell secretome: Implications for tumor modulation via cell-signaling pathways},
  journal = {International Immunopharmacology},
  year = {2024},
  volume = {143},
  pages = {113265},
  doi = {10.1016/j.intimp.2024.113265}
}
Kostenlos starten →